Chao Xingjuan, president and CEO of CBLL, has disclosed 51 Form 4 events across a single issuer — and none of them are buys. Aggregate open-market sales total $8,373,428.04, with $0 in reported open-market purchases, a one-directional disposition bias carried through every filing in the set. The filings cluster at roughly monthly intervals, each cycle showing the same mechanical structure: option exercises (code M) settled on the same day as open-market sales (code S). The most recent filing date, July 7, 2026, carried three sales worth $468,724.60, $278,600, and $28,775.40, alongside two option exercises. That pattern repeats on April 6, May 5, and June 8, 2026, with per-month sales of approximately $717,600, $783,973, and $714,870 respectively, each paired with $117,500 in option exercises. A standalone sale on May 21 added $108,540.
Across the last five months, the 13 recent sales total roughly $3.1 million — about 37% of the lifetime sell figure. No recent purchases appear; the only non-sale activity is a pair of zero-value stock awards (code A) reported April 1, 2026. The data supports a consistent, recurring exercise-and-sell cadence: shares acquired through option conversion are immediately liquidated in the open market, with no indication of cash deployment back into the stock. The March 25, 2026 filings also show option exercises of $69,350 and $82,046.72 without a large corresponding sale on that date, but the dominant pattern across the 51 filings is clear — steady selling of CBLL stock, escalating in the latest quarterly window.
AI-assisted summary